.png){kind=icon}
.png){kind=icon}
Return
Informing immunotherapy with multi-omics driven machine learning
.png){kind=icon}
OA
AI
DOI：10.1038/s41746-024-01043-6.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Progress in sequencing technologies and clinical experiments has revolutionized immunotherapy on solid and hematologic malignancies. However, the benefits of immunotherapy are limited to specific patient subsets, posing challenges for broader application. To improve its effectiveness, identifying biomarkers that can predict patient response is crucial. Machine learning (ML) play a pivotal role in harnessing multi-omic cancer datasets and unlocking new insights into immunotherapy. This review provides an overview of cutting-edge ML models applied in omics data for immunotherapy analysis, including immunotherapy response prediction and immunotherapy-relevant tumor microenvironment identification. We elucidate how ML leverages diverse data types to identify significant biomarkers, enhance our understanding of immunotherapy mechanisms, and optimize decision-making process. Additionally, we discuss current limitations and challenges of ML in this rapidly evolving field. Finally, we outline future directions aimed at overcoming these barriers and improving the efficiency of ML in immunotherapy research.
Keywords:
TUMOR MICROENVIRONMENT
ANTITUMOR IMMUNITY
NEURAL-NETWORKS
LUNG-CANCER
PREDICTION
DATABASE
LANDSCAPE
MELANOMA
BLOCKADE
REVEALS
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
15.1
Papers:
3.2K
Citations:
1.5W